Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vomiting 1Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1

Interventions

Aprepitant 8Dexamethasone 7Calcium Dobesilate 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Doxorubicin 5Vincristine 4Palonosetron 4Cyclophosphamide 4dexamethasone 21-phosphate 3Psychiatric Rehabilitation 3Granisetron 3peppermint oil 2auricularum 2Yoga 2Rituximab 2Music Therapy 2Mesna 2Lorazepam 2Ifosfamide 2Control Groups 2Aromatherapy 2Acupressure 2stinging nettle lectin 1salicylhydroxamic acid 1fosaprepitant 1dolasetron 1almond oil 1Whole Body Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Nausea × R-CHOP protocol × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡